Yixing Wu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Respiratory Support and Mechanisms 2
- Co-authors
- Lingeng Lu (6 shared papers)Lingwen Zeng (1 shared paper)Guodong Liu (1 shared paper)Zhuo Xiao (1 shared paper)Zhiyuan Fang (1 shared paper)Jing Huang (1 shared paper)Puchang Lie (1 shared paper)Yimin Liu (3 shared papers)
- Journals
- Frontiers in Medicine (2 papers)Chemical Communications (1 paper)European Journal of Cancer (1 paper)BMC Pulmonary Medicine (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yixing Wu
29 papers receiving 469 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 84
- Aging 7
- Molecular Biology 264
- Health, Toxicology and Mutagenesis 46
- Biochemistry 23
Countries citing papers authored by Yixing Wu
This map shows the geographic impact of Yixing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixing Wu more than expected).
Fields of papers citing papers by Yixing Wu
This network shows the impact of papers produced by Yixing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixing Wu. The network helps show where Yixing Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yixing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 101 | |
| 2 | 2009 | 85 | |
| 3 | 2018 | 71 | |
| 4 | 2012 | 60 | |
| 5 | 2023 | 16 | |
| 6 | 2014 | 15 | |
| 7 | 2023 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 13 | |
| 10 | 2024 | 12 | |
| 11 | 2024 | 9 | |
| 12 | 2013 | 8 | |
| 13 | 2018 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2006 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2023 | 4 | |
| 19 | Beneficial Changes on Body Composition and Circulating Adiponectin and hsCRP Levels Following One Year of Exenatide Therapy, Compared with Insulin Glargine, in Metformin-Treated Patients with Type 2 Diabetes | 2009 | 4 |
| 20 | 2024 | 3 |
About Yixing Wu
Yixing Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Physiology and Surgery, having authored 34 papers that have together received 474 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), MicroRNA in disease regulation (3 papers), Asthma and respiratory diseases (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Pediatric health and respiratory diseases (2 papers), Antifungal resistance and susceptibility (2 papers), Sexual function and dysfunction studies (2 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Cancer Research (84 citations), Aging (7 citations), Molecular Biology (264 citations), Health, Toxicology and Mutagenesis (46 citations) and Biochemistry (23 citations). Yixing Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Lingeng Lu, Lingwen Zeng, Guodong Liu, Zhuo Xiao, Zhiyuan Fang, Jing Huang, Puchang Lie, Yimin Liu, Cheng Zhang and Mario Preti. Their work appears in journals such as Frontiers in Medicine, Chemical Communications, European Journal of Cancer, BMC Pulmonary Medicine and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.